Why do you matter to your customers? Here's why creating a distinctive, authentic and compelling brand in today's world is so important.
Do you remember the first time you heard the word Swiffer? Skype? What about Tic Tac? They were new words, created by marketers to embody the brand of a new product or service. Now they have become familiar to most of us. So, how does this happen?
Get answers to common regulatory questions asked in healthcare and pharmaceuticals. We detail challenges around nonproprietary and proprietary drug naming
To understand your brand and measure its success, you must consistently conduct research with the most relevant stakeholders. Through brand tracking studies you’re able take into account the following measures: brand awareness, brand relevance, benefit believability, brand loyalty, and brand associations.
Drug names are weird, because they work and get approved. So throw out what you *think* you want in a name and work with a team who understands how to creatively and successfully navigate global regulatory restrictions in pharma.
Finding someone to create names is easy – but for a successful outcome, you need an experienced, skilled branding partner adept at managing both creative and legal pathways.
How do you create a brand name that sticks? Are there tools or insights that will help create memorability with your customers? The answer is yes!
In a society so bombarded with choices, it can sometimes be difficult for brands to stand out. A strategic method for grasping attention is to capture them in one of their first interactions with your company or product: the brand name.
Human factor is a term used to describe the application of the knowledge of human abilities and limitations to the design of medical devices. Why is the FDA concerned with studies of human factors? Human factors influence the safety and efficacy of a device. Failures in the use of medical devices are often not the fault of the device itself but how humans interact with it. Addison Whitney’s center for regulatory guidance series it’s not that complicated looks behind the curtain, and breaks down the common questions and challenges around gaining regulatory approval.
Of course you know about Software as a Product (SaaP). These days, you may even regularly use Software as a Service (SaaS). But one of the fastest-growing technology areas is Software as a Medical Device (SaMD). With healthcare at the forefront of many people’s minds, creation of wellness solutions is becoming a highly competitive space.
When developing a new brand, name, or logo, it may seem like there is one obvious choice of decision-making criteria that should be the main determinant. In reality, there is a whole tool box of decision-making criteria that a company should consider and weigh to make final decisions around their brand.
Are you struggling to understand the timing required to get a brand name approved? Or the considerations to take after a rejection, withdrawal or proposal of a new name? The answer to these questions and related questions is – PDUFA!
We recently read an article that stated “branding is something you do after someone has bought from you, rather than something you do to induce them to buy from you” – and we take issue with that statement.
In a world completely inundated with information, where voices struggle to be heard over one another, it has become increasingly common that we marginalize the perspectives that deserve to be the loudest ones heard.
When creating your positioning strategy, there are two main aspects to use as starting points – function or feeling. But which one’s right for your brand?
Too difficult. Unoriginal. Hard to remember. These are the words that no company wants to hear about their latest brand name. This is especially true in the pharmaceutical industry, where the name of a drug is crucial to its approval and success. How can a blank canvas naming strategy address these concerns?
As brands and logos have evolved over the last several years, it’s become evident that simplicity and minimalistic design are key directions for modern brand marketing.
Learn how the alignment of brand and business strategy can enliven internal teams, sharpen external communication and unleash market success.
How your brand presents itself through the transition could make a big impact on both customers and employees.
A brand is a vessel carrying values and beliefs that consumers associate with a product or service, but it doesn’t start out that way.
In June the EMA NRG held their annual meeting to discuss guidelines, best practices and trends for invented name submissions. Review our summary to stay up-to-date on the latest changes.
If AI is the wave of the future, we must keep in mind the shortcomings: right now smart computer systems only consider the tip of the iceberg when it comes to drug naming.
Biosimilars are one of the most exciting breakthroughs in the pharmaceutical space in years, providing an entirely new category of products to reach patients. But with this new innovation comes new branding challenges.
2017 was a busy year for regulatory updates. Download our webinar to learn more about the changes we saw within the FDA, EMA and Health Canada.
Mergers, acquisitions, restructurings – don’t let your brand suffer during times of change at the corporate level.
How to build a brand in a way that successfully communicates the previously unseen nature of innovation? The answer can be found in one word – differentiation.
Do you choose a name that is “safe” and has a good chance at regulatory approval, or to take the more “risky” route, with a name that might have a more difficult time getting approved but stands out?
Just like you wouldn't build a house without a blueprint created, you shouldn't build a brand without a brand architecture strategy in place. Find out why this strategic brand element can drive all of your brand development decisions.
Branding clinical trials helps you begin building equity in your clinical asset in its earliest phases of development. Find out how this benefits you, your patients and even investors.
Creating and growing any business is a process that can take large amounts of time and energy to achieve – that’s a given. It’s a question we hear all of the time – “why do I need to create a brand? Why branding?”
Creating a brand name with links back to the science of the product holds a number of benefits and advantages across your brand.
Is there something “off” with your brand, and you can’t figure out what it is? Chances are, your brand is in need of a refresh.
Is it possible to convey both competence and warmth in a logo? Unity and inclusion? Strength and kindness? The answer to all of the above is yes and no. It’s certainly possible for a logo to convey any or all of those things – just not on its own.
We’ve compiled answers for the 11 most frequently asked questions surrounding pharmaceutical branding we receive today to help you with your next project.
How often have you scanned the store shelves looking for a product, and a particular one caught your eye, making you stop, do a double-take or spend a few additional seconds focusing on that one product before moving on? Well, those few seconds and that additional look were not a coincidence.
Naming an OTC drug product is the rare instance in pharma naming when pre- and post-launch planning are so closely intertwined, which can pose some challenges. But it can also some uniquely interesting opportunities. What do you need to keep in mind when working on this type of product?
It has been said that you never get a second chance to make a first impression. For many new assets the clinical trial stage of development is that first impression, a chance to ensure that moving forward, their brand is set up for success.
How can your colors push your brand forward, and what do you need to keep in mind when making decisions about your color palette?
When creating a pharma brand name, the thin line must be walked between creating a name that will have both a strong opportunity for regulatory approval and the recipe for market success.
In the summer of 2015, Health Canada released an updated guidance for their name submission process. Almost two years later, found an impact that goes beyond the Canadian pharmaceutical market.